117th Congress · HOUSE BILLBILL

H.R. 9011Updated Drug Labeling for Patient Safety Act

To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish a process to allow the holders of abbreviated new drug applications to make labeling changes to include new or updated safety-related information, and for other purposes.

Health
Introduced Sep 28, 2022
Last action Sep 29, 2022
Pipeline · Bill → Law
Step 1
Introduced
Sep 28, 2022
Step 2
Referred
Sep 29, 2022
E&C
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House
Timeline · 3 actions
Sep 29, 2022
Referred to the Subcommittee on Health.
Sep 28, 2022
Introduced in House
Sep 28, 2022
Referred to the House Committee on Energy and Commerce.